REFERENZEN BILDGEBUNG IN DER RHEUMATOLOGIE
1: Sewerin P, Le L, Vordenbäumen S, Schleich C, Sengewein R, Brinks R, Pongratz G, Bleck E, Lesch J, Mansmann U, Schneider M, Ostendorf B. Rheumatoid Arthritis Magnetic Resonance Imaging Score Predicts Therapy Response: Results of the German ArthroMark Cohort. J Rheumatol. 2018 Apr 1;jrheum.170797.
2: Sewerin P, Müller-Lutz A, Abrar D, Odendahl S, Eichner M, Schneider M, Ostendorf B, Schleich C. Prevention of the Progressive Biochemical Cartilage Destruction under Methotrexate Therapy in Early Rheumatoid Arthritis. Clin Exp Rheumatol.2018.
3: Sewerin P, Ostendorf B, Hueber AJ, Kleyer A. Big Data in der Bildgebung. Z Für Rheumatol. 2018 Apr;77(3):203–8.
4: Frenken M, Schleich C, Brinks R, Abrar DB, Goertz C, Schneider M, Ostendorf B, Sewerin P.The value of the simplified RAMRIS-5 in early RA patients under methotrexate therapy using high-field MRI. Arthritis Res Ther. 2019 Jan 14;21(1):21. doi: 10.1186/s13075-018-1789-3.
5: Pongratz G, Lowin T, Sewerin P, Zaucke F, Jenei-Lanzl Z, Pauly T, Ostendorf B, Schneider M Tryptophan metabolism in rheumatoid arthritis is associated with rheumatoid factor and predicts joint pathology evaluated by the Rheumatoid Arthritis MRI Score (RAMRIS).,Clin Exp Rheumatol. 2018 Nov 16. [Epub ahead of print]PMID: 30557125
6: Mori V, Sawicki LM, Sewerin P, Eichner M, Schaarschmidt BM, Oezel L, Gehrmann S, Bittersohl B, Antoch G, Schleich C. Differences of radiocarpal cartilage alterations in arthritis and osteoarthritis using morphological and biochemical magnetic resonance imaging without gadolinium-based contrast agent administration. Eur Radiol. 2018 Dec 12. doi: 10.1007/s00330-018-5880-6. [Epub ahead of print]5.
7: Sewerin P, Schleich C, Vordenbäumen S, Ostendorf B. Update on imaging in rheumatic diseases: cartilage. Clin Exp Rheumatol. 2018 Sep-Oct;36 Suppl 114(5):139-144. Epub 2018 Oct 1. Review.
8: Sewerin P, Brinks R, Schneider M, Haase I, Vordenbäumen S.Prevalence and incidence of psoriasis and psoriatic arthritis. Ann Rheum Dis. 2019 Feb;78(2):286-287. doi: 10.1136/annrheumdis-2018-214065.
9: Sewerin P, Müller-Lutz A, Abrar DB, Odendahl S, Eichner M, Schneider M, Ostendorf B, Schleich C. Prevention of the progressive biochemical cartilage destruction under methotrexate therapy in early rheumatoid arthritis. Clin Exp Rheumatol. 2018 Jun 7. [Epub ahead of print]
10: Sewerin P, Ostendorf B, Schleich C. MRI diagnostics in inflammatory joint and spinal diseases: protocols and special sequences: when and for what? Z Rheumatol. 2018 Jun 18. doi: 10.1007/s00393-018-0497-3. [Epub ahead of print] Review. German.
11: Häupl T, Skapenko A, Hoppe B, Skriner K, Burkhardt H, Poddubnyy D, Ohrndorf S, Sewerin P, Mansmann U, Stuhlmüller B, Schulze-Koops H, Burmester GR. Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark. Z Rheumatol. 2018 May;77(Suppl 1):16-23. doi: 10.1007/s00393-018-0458-x. Review. German.
12: Sewerin P, Le L, Vordenbäumen S, Schleich C, Sengewein R, Brinks R, Pongratz G, Bleck E, Lesch J, Mansmann U, Schneider M, Ostendorf B. Rheumatoid Arthritis Magnetic Resonance Imaging Score Predicts Therapy Response: Results of the German ArthroMark Cohort. J Rheumatol. 2018 Jun;45(6):753-759. doi: 10.3899/jrheum.170797. Epub 2018 Apr 1.